These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24024196)

  • 21. Evaluating How Post-Bronchodilator Vital Capacities Affect the Diagnosis of Obstruction in Pulmonary Function Tests.
    Blagev DP; Sorenson D; Linares-Perdomo O; Bamberg S; Hegewald M; Morris AH
    Respir Care; 2016 Nov; 61(11):1523-1529. PubMed ID: 27624631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The "Complex Restrictive" Pulmonary Function Pattern: Clinical and Radiologic Analysis of a Common but Previously Undescribed Restrictive Pattern.
    Clay RD; Iyer VN; Reddy DR; Siontis B; Scanlon PD
    Chest; 2017 Dec; 152(6):1258-1265. PubMed ID: 28728932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease].
    Baloira Villar A; Vilariño Pombo C
    Arch Bronconeumol; 2005 Mar; 41(3):130-4. PubMed ID: 15766465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is a 'restrictive' defect?
    Gilbert R; Auchincloss JH
    Arch Intern Med; 1986 Sep; 146(9):1779-81. PubMed ID: 3753118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.
    Anzueto A; Wise R; Calverley P; Dusser D; Tang W; Metzdorf N; Dahl R
    Respir Res; 2015 Sep; 16(1):107. PubMed ID: 26369563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and nature of lung function abnormalities among Indigenous Australians referred to specialist respiratory outreach clinics in the Northern Territory.
    Schubert J; Kruavit A; Mehra S; Wasgewatta S; Chang AB; Heraganahally SS
    Intern Med J; 2019 Feb; 49(2):217-224. PubMed ID: 30239090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spirometric changes in obstructive disease: after all, how much is significant?
    Soares AL; Pereira CA; Rodrigues SC
    J Bras Pneumol; 2013; 39(1):56-62. PubMed ID: 23503486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction.
    Watson A; Lim TK; Joyce H; Pride NB
    Chest; 1992 Feb; 101(2):350-5. PubMed ID: 1735253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forced expiratory volumes in 3 s is a sensitive clinical measure for assessment of bronchodilator reversibility in elderly Chinese with severe lung function impairment.
    Pan M; Zhang H; Sun T
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1803-1811. PubMed ID: 31496679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.
    Rennard SI; Serby CW; Ghafouri M; Johnson PA; Friedman M
    Chest; 1996 Jul; 110(1):62-70. PubMed ID: 8681667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative spirometry and perioperative drug therapy in patients with obstructive pulmonary dysfunction.
    Takiguchi H; Niimi K; Tomomatsu H; Tomomatsu K; Hayama N; Oguma T; Aoki T; Urano T; Asai S; Miyachi H; Abe T; Asano K
    Tokai J Exp Clin Med; 2014 Sep; 39(3):151-7. PubMed ID: 25248432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COPD in the elderly. A reversible cause of functional impairment.
    Chang JT; Moran MB; Cugell DW; Webster JR
    Chest; 1995 Sep; 108(3):736-40. PubMed ID: 7656625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-bronchodilator spirometry reference values in adults and implications for disease management.
    Johannessen A; Lehmann S; Omenaas ER; Eide GE; Bakke PS; Gulsvik A
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1316-25. PubMed ID: 16556696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia.
    Bar-Aluma BE; Efrati O; Kaufmann H; Palma JA; Norcliffe-Kaufmann L
    Lung; 2018 Feb; 196(1):93-101. PubMed ID: 29234869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Response to inhaled bronchodilators in chronic airway obstruction].
    Holten K
    Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional lung response to bronchodilator reversibility testing determined by electrical impedance tomography in chronic obstructive pulmonary disease.
    Vogt B; Zhao Z; Zabel P; Weiler N; Frerichs I
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L8-L19. PubMed ID: 27190067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute bronchodilator responsiveness to tiotropium in postinfectious bronchiolitis obliterans in children.
    Teixeira MFC; Rodrigues JC; Leone C; Adde FV
    Chest; 2013 Sep; 144(3):974-980. PubMed ID: 23558666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstructive and restrictive pulmonary dysfunctions in Parkinson's disease.
    Sabaté M; González I; Ruperez F; Rodríguez M
    J Neurol Sci; 1996 Jun; 138(1-2):114-9. PubMed ID: 8791248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.